Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 6908924 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kyoichi A. Watanabe0

Junxing Shi0

Michael J. Otto0

Date of Patent

June 21, 2005

0

Patent Application Number

103203500

Date Filed

December 16, 2002

0

Patent Citations Received

US Patent 12084473 β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment

0

US Patent 11975016 2′-substituted-N

0

US Patent 12121529 Nucleoside phosphoramidate prodrugs

0

US Patent 12006340 Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus

0

Patent Primary Examiner

Thomas C. McKenzie

0

Patent abstract

The present invention is directed to a compound, method and composition of treating or preventing viral infections, in particular, human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections, in human patients or other animal hosts, comprising the administration of N4-acylcytosine-1,3-dioxolane and pharmaceutically acceptable salts, prodrugs, and other derivatives thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 6908924 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool